Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 183 entries
View as:

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00358098 Org: User:
Start: 08/31/06 End: 06/30/13 Due: 06/30/14

A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant

Phase: N/A Priority: Normal
NCT ID: NCT01437085 Org: User:
Start: 10/31/11 End: 08/31/17 Due: 08/31/18

A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02152059 Org: User:
Start: 07/31/14 End: 07/31/16 Due: 07/31/17

MVCT Imaging Pilot Study Using Helical Tomotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00168142 Org: User:
Start: 10/31/03 End: 08/31/09 Due: 08/31/10

A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05370144 Org: User:
Start: 02/08/23 End: 02/03/28 Due: 02/03/29

Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00643396 Org: User:
Start: 02/29/08 End: 01/31/12 Due: 01/31/13

Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00122265 Org: User:
Start: 04/30/03 End: 01/31/12 Due: 01/31/13

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01065805 Org: User:
Start: 03/20/09 End: 02/25/19 Due: 02/25/20

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05040815 Org: User:
Start: 05/11/23 End: 05/31/28 Due: 05/31/29

An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)

Phase: N/A Priority: Normal
NCT ID: NCT01747512 Org: User:
Start: - End: - Due: -

Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Phase: N/A Priority: Normal
NCT ID: NCT00314522 Org: User:
Start: 09/30/05 End: 03/31/06 Due: 03/31/07

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Phase: N/A Priority: Normal
NCT ID: NCT00123773 Org: User:
Start: 04/30/04 End: 12/31/08 Due: 12/31/09

APBI: 27Gy in 5 Fractions for Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02681107 Org: User:
Start: 05/31/16 End: 07/31/21 Due: 07/31/22

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT00530283 Org: User:
Start: 08/31/07 End: 07/31/10 Due: 07/31/11

A Phase III Study of Re-Irradiation in Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01830101 Org: User:
Start: 02/28/14 End: 11/30/17 Due: 11/30/18

Blood Test to Measure DNA Damage in Blood

Phase: N/A Priority: Normal
NCT ID: NCT00523471 Org: User:
Start: 07/31/07 End: 06/30/10 Due: 06/30/11

To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01437254 Org: User:
Start: 10/31/11 End: 01/31/15 Due: 01/31/16

A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin

Phase: N/A Priority: Normal
NCT ID: NCT01157039 Org: User:
Start: 10/31/11 End: - Due: -

PET/MRI in Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06057831 Org: User:
Start: 05/31/26 End: 12/31/30 Due: 12/31/31

TORI 104 Pre-Surgical Dasatinib

Phase: N/A Priority: Normal
NCT ID: NCT01410708 Org: User:
Start: - End: - Due: -

A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely

Phase: N/A Priority: Normal
NCT ID: NCT03175146 Org: User:
Start: 09/30/17 End: 01/31/21 Due: 01/31/22

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00351962 Org: User:
Start: 09/30/06 End: 07/02/14 Due: 07/02/15

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00126867 Org: User:
Start: 05/31/05 End: 04/11/19 Due: 04/11/20

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Phase: N/A Priority: Normal
NCT ID: NCT00130936 Org: User:
Start: 10/31/05 End: 11/30/07 Due: 11/30/08

The Breast Cancer & Physical Activity Level (BC-PAL) Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT03564899 Org: User:
Start: 02/13/17 End: 12/31/18 Due: 12/31/19